Galmed Pharmaceuticals (GLMD) Change in Cash (2013 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Change in Cash of $671000.0 in Q4 2025, up 140.69% quarter-over-quarter from -$1.6 million in Q3 2025, and up 113.23% on a YoY basis from $314676.7 in Q4 2024.
Galmed Pharmaceuticals (GLMD) Change in Cash (2013 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Change in Cash history runs 13 years deep, the most recent figure standing at $671000.0 for Q4 2025.
- In Q4 2025, Change in Cash rose 113.23% year-over-year to $671000.0; the TTM figure through Dec 2025 stood at -$664000.0 (down 136.99% YoY), while the FY2025 annual figure was -$664000.0, down 136.99% from the prior year.
- Change in Cash was $671000.0 for Q4 2025 at Galmed Pharmaceuticals, up from -$1.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $7.9 million in Q3 2024 to a low of -$5.5 million in Q2 2021.
- Historically, Change in Cash has averaged -$147550.0 across 5 years, with a median of -$212500.0 in 2022.
- Biggest YoY gain for Change in Cash was 1567.65% in 2024; the steepest drop was 467.13% in 2024.
- A 5-year view of Change in Cash shows it stood at -$605000.0 in 2021, then tumbled by 238.02% to -$2.0 million in 2022, then soared by 167.53% to $1.4 million in 2023, then tumbled by 467.13% to -$5.1 million in 2024, then jumped by 113.23% to $671000.0 in 2025.
- The last three Change in Cash figures came in at $671000.0 (Q4 2025), -$1.6 million (Q3 2025), and $198000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | 671,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 671,000.00 |
| Sep 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 473,000.00 |
| Jun 30, 2023 | -662,000.00 |
| Mar 31, 2023 | -344,000.00 |
| Dec 31, 2022 | -2.05 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | -823,000.00 |
| Mar 31, 2022 | -81,000.00 |
| Dec 31, 2021 | -605,000.00 |
| Sep 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -5.46 Mn |
| Mar 31, 2021 | 6.44 Mn |